Brian Cheng
Director/Board Member at JUBILANT FLAME INTERNATIONAL, LTD.
Net worth: 11 400 $ as of 2024-04-29
Profile
Brian Cheng is currently the Director at Jubilant Flame International Ltd.
and also holds the position of Chief Technical Officer & Director at Biomark Technologies, Inc. He previously worked as a Manager-Operation Excellent at Mallinckrodt Pharmaceuticals Ltd.
Mr. Cheng has a graduate degree from the University of Washington and an undergraduate degree from Indiana University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-05-11 | 300,000 ( 1.50% ) | 11 400 $ | 2024-04-29 |
Brian Cheng active positions
Companies | Position | Start |
---|---|---|
JUBILANT FLAME INTERNATIONAL, LTD. | Director/Board Member | 2019-01-14 |
Biomark Technologies, Inc. | Chief Tech/Sci/R&D Officer | - |
Former positions of Brian Cheng
Companies | Position | End |
---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Corporate Officer/Principal | - |
Training of Brian Cheng
Indiana University | Undergraduate Degree |
University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JUBILANT FLAME INTERNATIONAL, LTD. | Retail Trade |
Private companies | 2 |
---|---|
Biomark Technologies, Inc. | |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
- Stock Market
- Insiders
- Brian Cheng